We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Cranberry Capsules on Urinary Infection Rates in Spinal Cord Injured Patients During Post Acute Rehabilitation

This study has been terminated.
(Terminated early due to recruitment difficulties)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01079169
First Posted: March 3, 2010
Last Update Posted: May 16, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Uppsala University
  Purpose
The purpose of this study is to establish whether cranberry capsules reduce rates of urinary tract infections during initial rehabilitation immediately after spinal cord injury.

Condition Intervention
Spinal Cord Injury Urinary Tract Infection Rehabilitation Dietary Supplement: Cranberry capsules

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Prevention
Official Title: Evaluation of the Effect of Cranberry Capsules on the Occurrence of Urinary Tract Infections During Post-acute Rehabilitation of Spinal Cord Injured Patients

Resource links provided by NLM:


Further study details as provided by Uppsala University:

Primary Outcome Measures:
  • Number of symptomatic urinary tract infections per patient per month during in-patient post acute rehabilitation [ Time Frame: At end of study ]

Secondary Outcome Measures:
  • Percentage of in-patient rehabilitation days on which patients were unable to participate in active rehabilitation due to urinary tract infection. [ Time Frame: At end of Study ]
  • Patient's experience of urinary symptoms in the absence of symptomatic urinary tract infection. [ Time Frame: At end of study ]

Enrollment: 3
Study Start Date: March 2010
Study Completion Date: March 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Cranberry capsule Dietary Supplement: Cranberry capsules
Cranberry capsules, 550mg, or placebo capsules, two capsules three times daily during in-patient rehabilitation
Placebo Comparator: Placebo capsule Dietary Supplement: Cranberry capsules
Cranberry capsules, 550mg, or placebo capsules, two capsules three times daily during in-patient rehabilitation

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Previously essentially healthy
  2. Newly acquired spinal cord injury, T12 level or higher
  3. Receiving in-patient care on the rehabilitation ward.
  4. Expected admission duration >= 4 weeks
  5. 16 years old or older

Exclusion Criteria:

  1. Current or previous disorder that increases the risk of urinary tract infection including diabetes, urological disorder, previous operation on urinary tracts or kidneys, immune dysfunction
  2. Severe head injury with impairment of cognitive function
  3. Allergy to cranberry
  4. Renal failure
  5. Warfarin (Coumarin) treatment with unstable INR
  6. Current symptomatic urinary tract infection
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01079169


Locations
Sweden
Dept of Rehabilitation Medicine, University Hospital
Uppsala, Sweden, 75185
Sponsors and Collaborators
Uppsala University
Investigators
Principal Investigator: Alison K Godbolt, MbChB MD University Hospital Uppsala
  More Information

Responsible Party: Uppsala University
ClinicalTrials.gov Identifier: NCT01079169     History of Changes
Other Study ID Numbers: 2009/280
First Submitted: February 19, 2010
First Posted: March 3, 2010
Last Update Posted: May 16, 2016
Last Verified: May 2016

Keywords provided by Uppsala University:
urinary tract infection
prevention
rehabilitation
spinal cord injury

Additional relevant MeSH terms:
Infection
Communicable Diseases
Spinal Cord Injuries
Urinary Tract Infections
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Urologic Diseases